GL1X · GenesisL1 explorer

MolNFT v1 · #177098 · protein

Cryo-EM structure of the SARS-cov-2 wild-type S-trimer from a subunit vaccine candidate

7E7D · Spike GLYCOPROTEIN,COLLAGEN alpha-1(I) chain: “Cryo-EM structure of the SARS-cov-2 wild-type S-trimer from a subunit vaccine candidate”. Electron microscopy, 2 ligands (ELA, NAG), 20 pockets (best druggability 0.86). MolNFT v1…

PDB
7E7D
Type
protein
Length
3,240 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike GLYCOPROTEIN,COLLAGEN alpha-1(I) chain
UniProt
P0DTC2
Ligands
ELA, NAG
Pockets
20 · best druggability 0.86

Structure

electron microscopy · 1 distinct chain · 24% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CSpike GLYCOPROTEIN,COLLAGEN alpha-1(I) chainprotein108024% helix, 32% strandP0DTC2

Ligands and binding sites

  • ELA · 9-octadecenoic acid · ligand · 3 copies · chains A, C, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 83 copies · chains B, A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110690.860.87159empty
22200.850.9733ELA
39610.840.86124empty
48490.840.8799empty
57520.840.8790empty

Interfaces

3 interfaces between chains.

  • B–C · 6778 Ų buried · 60 hydrogen bonds · protein-protein
  • A–B · 6764 Ų buried · 66 hydrogen bonds · protein-protein
  • A–C · 6539 Ų buried · 54 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 51 glycan, 42 disulfide (N-glycosylation, disulfide).

Compared structures

  • 7E7D · Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.